{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-014652","form_type":"8-K","ticker":"LTRN","cik":"0001763950","company_name":"Lantern Pharma Inc.","filed_at":"2025-09-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.915167+00:00","generated_at":"2026-05-17T05:53:35.393649+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Lantern Pharma shareholders elect all six directors, approve option repricing, ratify auditor at 2025 annual meeting","bullets":["All six director nominees elected: Keyser (2.21M for), Sharma (2.21M), Chandru (2.20M), Maccecchini (2.21M), Schalop (2.21M), Silberstein (2.21M); broker non-votes 5.19M.","One-time repricing of stock options under 2018 Equity Incentive Plan approved: 1.46M for, 759K against, 30K abstain, 5.19M broker non-votes.","Ratification of EisnerAmper LLP as auditor for FY2025 passed: 7.37M for, 44K against, 26K abstain; no broker non-votes on this item."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-014652","json":"https://secwatch.observer/filing/0001493152-25-014652.json","markdown":"https://secwatch.observer/filing/0001493152-25-014652.md","text":"https://secwatch.observer/filing/0001493152-25-014652.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1763950/000149315225014652/0001493152-25-014652-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1763950/000149315225014652/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T05:53:35.393649+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}